Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nuclear Transmutation03:20

Nuclear Transmutation

17.6K
Nuclear transmutation is the conversion of one nuclide into another. It can occur by the radioactive decay of a nucleus, or the reaction of a nucleus with another particle. The first manmade nucleus was produced in Ernest Rutherford’s laboratory in 1919 by a transmutation reaction, the bombardment of one type of nuclei with other nuclei or with neutrons. Rutherford bombarded nitrogen-14 atoms with high-speed α particles from a natural radioactive isotope of radium and observed...
17.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Morita Therapy-Based Nursing Support for Socially Withdrawn Japanese Youth (Hikikomori) with Gaze Phobia: A Case Report.

Reports (MDPI)·2026
Same author

Identifying predictive hematological biomarkers for radiation exposure by machine learning in mouse models.

Communications medicine·2026
Same author

Stable and tunable MeV γ-ray generation via dual-laser inverse Thomson scattering from a laser-plasma accelerator.

Scientific reports·2026
Same author

FLASH reduces radiation-induced oral mucositis in a mouse model of Fanconi anemia.

bioRxiv : the preprint server for biology·2026
Same author

A quantitative proteomics dataset for assessment and prediction of low dose X-ray radiation exposure in mice.

bioRxiv : the preprint server for biology·2026
Same author

Spherical radiomics for radiogenomic assessment of glioblastoma heterogeneity.

Neuro-oncology advances·2026
Same journal

Non-Thermal Plasma Accelerates Astrocyte Regrowth and Neurite Regeneration Following Physical Trauma In Vitro.

Applied sciences (Basel, Switzerland)·2026
Same journal

The Basic Reproduction Number for Petri Net Models: A Next-Generation Matrix Approach.

Applied sciences (Basel, Switzerland)·2026
Same journal

Tetracenomycin Aglycones Primarily Inhibit Cell Growth and Proliferation in Mammalian Cancer Cell Lines.

Applied sciences (Basel, Switzerland)·2026
Same journal

Neuroengineering Frontiers: A Selective Review of Neural Interfaces, Brain-Machine Interactions, and Artificial Intelligence in Neurodegenerative Diseases.

Applied sciences (Basel, Switzerland)·2026
Same journal

Engineering Brain Injury In Vitro: Human iPSC-Based Organoids in Microfluidic Systems.

Applied sciences (Basel, Switzerland)·2026
Same journal

Comparing Virtual Reality and Robotic Training Effects on Balance Ability and Confidence in Older Adults.

Applied sciences (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Jul 5, 2025

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
08:30

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on: September 11, 2011

14.4K

Transformative Technology for FLASH Radiation Therapy.

Reinhard Schulte1, Carol Johnstone2, Salime Boucher3

  • 1Division of Biomedical Engineering Sciences, Loma Linda University, Loma Linda, CA 92350, USA.

Applied Sciences (Basel, Switzerland)
|January 19, 2024
PubMed
Summary
This summary is machine-generated.

FLASH radiation therapy (FLASH-RT) uses ultra-high dose rates to spare normal tissues while effectively killing tumors. This novel approach offers a new paradigm for cancer treatment, but technical challenges remain for widespread adoption.

Keywords:
FLASH effectparticle acceleratorsradiation therapy

More Related Videos

Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy
11:24

Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy

Published on: October 18, 2011

14.7K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.7K

Related Experiment Videos

Last Updated: Jul 5, 2025

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
08:30

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on: September 11, 2011

14.4K
Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy
11:24

Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy

Published on: October 18, 2011

14.7K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.7K

Area of Science:

  • Medical Physics
  • Oncology
  • Radiation Biology

Background:

  • Conventional radiation therapy aims to maximize tumor damage while minimizing normal tissue toxicity through precise dose delivery.
  • Normal tissue toxicity remains a significant limitation in current cancer treatment, impacting patient outcomes and treatment efficacy.
  • The therapeutic index of radiation therapy is constrained by the balance between tumor control and radiation-induced side effects.

Purpose of the Study:

  • To introduce and explore the potential of FLASH radiation therapy (FLASH-RT) as a novel paradigm for cancer treatment.
  • To highlight the preclinical evidence supporting the differential effect of ultra-high dose rate radiation on tumors versus normal tissues.
  • To identify the technical challenges associated with implementing FLASH-RT using novel accelerator technologies.

Main Methods:

  • Utilizing ultra-high dose rates for radiation delivery, with doses administered in fractions of a second (typically < 200 ms).
  • Leveraging preclinical research to investigate the biological effects of FLASH-RT on tumor and normal tissues.
  • Exploring the development of novel compact accelerators capable of generating the required ultra-high dose rates.

Main Results:

  • Experimental studies indicate that normal tissues exhibit significant sparing under FLASH-RT conditions.
  • Tumor cells appear to be effectively eradicated at ultra-high dose rates, similar to conventional doses.
  • A differential effect favoring normal tissue protection over tumor cell kill has been observed consistently.

Conclusions:

  • FLASH-RT represents a promising new strategy to improve the therapeutic index in radiation oncology.
  • The sparing of normal tissues at ultra-high dose rates offers a potential solution to reduce treatment-related toxicities.
  • Overcoming technical challenges in accelerator design and dose delivery is crucial for the clinical translation of FLASH-RT.